mcc-555 has been researched along with azoxymethane in 1 studies
Studies (mcc-555) | Trials (mcc-555) | Recent Studies (post-2010) (mcc-555) | Studies (azoxymethane) | Trials (azoxymethane) | Recent Studies (post-2010) (azoxymethane) |
---|---|---|---|---|---|
26 | 0 | 5 | 1,766 | 1 | 745 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, SJ; Imchen, T; Manasse, J; Min, KW | 1 |
1 other study(ies) available for mcc-555 and azoxymethane
Article | Year |
---|---|
Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.
Topics: Aberrant Crypt Foci; Animals; Antineoplastic Agents; Apoptosis; Azoxymethane; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred Strains; Mitosis; Mucin-2; PPAR gamma; Thiazolidinediones | 2013 |